» Articles » PMID: 22678432

Determination of Site-specific Glycan Heterogeneity on Glycoproteins

Overview
Journal Nat Protoc
Specialties Biology
Pathology
Science
Date 2012 Jun 9
PMID 22678432
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

The comprehensive analysis of protein glycosylation is a major requirement for understanding glycoprotein function in biological systems, and is a prerequisite for producing recombinant glycoprotein therapeutics. This protocol describes workflows for the characterization of glycopeptides and their site-specific heterogeneity, showing examples of the analysis of recombinant human erythropoietin (rHuEPO), α1-proteinase inhibitor (A1PI) and immunoglobulin (IgG). Glycoproteins of interest can be proteolytically digested either in solution or in-gel after electrophoretic separation, and the (glyco)peptides are analyzed by capillary/nano-liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS). If required, specific glycopeptide enrichment steps, such as hydrophilic interaction liquid chromatography (HILIC), can also be performed. Particular emphasis is placed on data interpretation and the determination of site-specific glycan heterogeneity. The described workflow takes approximately 3-5 d, including sample preparation and data analysis. The data obtained from analyzing released glycans of rHuEPO and IgG, described in the second protocol of this series (10.1038/nprot.2012.063), provide complementary detailed glycan structural information that facilitates characterization of the glycopeptides.

Citing Articles

Integrated proteomics and N-glycoproteomic characterization of glioblastoma multiform revealed N-glycosylation heterogeneities as well as alterations in sialyation and fucosylation.

Hu M, Xu K, Yang G, Yan B, Yang Q, Wang L Clin Proteomics. 2025; 22(1):6.

PMID: 39923034 PMC: 11807306. DOI: 10.1186/s12014-025-09525-9.


Quantitative High-Throughput and High-Sensitivity Glycoprofile Analysis of Therapeutic Glycoproteins Using HILIC-FLD and ESI-MS.

Xie Y, Butler M Methods Mol Biol. 2024; 2853:249-263.

PMID: 39460925 DOI: 10.1007/978-1-0716-4104-0_16.


Quantitative profiling of N-glycosylation of SARS-CoV-2 spike protein variants.

Xie Y, Butler M Glycobiology. 2023; 33(3):188-202.

PMID: 36723867 PMC: 10114651. DOI: 10.1093/glycob/cwad007.


Determination of monosaccharide composition in human serum by an improved HPLC method and its application as candidate biomarkers for endometrial cancer.

Chen Y, Yao Q, Zeng X, Hao C, Li X, Zhang L Front Oncol. 2022; 12:1014159.

PMID: 36408150 PMC: 9671074. DOI: 10.3389/fonc.2022.1014159.


Glycosylation and the global virome.

Pegg C, Schulz B, Neely B, Albery G, Carlson C Mol Ecol. 2022; 32(1):37-44.

PMID: 36217579 PMC: 10947461. DOI: 10.1111/mec.16731.


References
1.
Christiansen M, Kolarich D, Nevalainen H, Packer N, Jensen P . Challenges of determining O-glycopeptide heterogeneity: a fungal glucanase model system. Anal Chem. 2010; 82(9):3500-9. DOI: 10.1021/ac901717n. View

2.
Wada Y, Dell A, Haslam S, Tissot B, Canis K, Azadi P . Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics. 2009; 9(4):719-27. PMC: 2860227. DOI: 10.1074/mcp.M900450-MCP200. View

3.
Pan S, Chen R, Aebersold R, Brentnall T . Mass spectrometry based glycoproteomics--from a proteomics perspective. Mol Cell Proteomics. 2010; 10(1):R110.003251. PMC: 3013464. DOI: 10.1074/mcp.R110.003251. View

4.
Kolarich D, Turecek P, Weber A, Mitterer A, Graninger M, Matthiessen P . Biochemical, molecular characterization, and glycoproteomic analyses of alpha(1)-proteinase inhibitor products used for replacement therapy. Transfusion. 2006; 46(11):1959-77. DOI: 10.1111/j.1537-2995.2006.01004.x. View

5.
Kolarich D, Altmann F, Sunderasan E . Structural analysis of the glycoprotein allergen Hev b 4 from natural rubber latex by mass spectrometry. Biochim Biophys Acta. 2006; 1760(4):715-20. DOI: 10.1016/j.bbagen.2005.11.012. View